Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering
SAN DIEGO, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of...
Staff
Operational and Financial Results for the Period Ended September 30, 2020
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
Significant Reduction in Triglyceride Levels Without Low-Density Lipoprotein Cholesterol (LDL-C) Increase Compared to Placebo and Safety Profile Similar to Placebo...
Aurora Spine Corporation Announces Financial Results for Third Quarter
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Gross margin improves to 48%, revealing company...
Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 – Conference Call to Follow
WINNIPEG, Manitoba, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics
WESTLAKE VILLAGE, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development...
LifeLabs reports surpassing 800,000 COVID-19 molecular tests
Toronto, Nov. 19, 2020 (GLOBE NEWSWIRE) -- LifeLabs is pleased to report results of over 800,000 COVID-19 molecular diagnostic tests...
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L
Initial Focus on Acute Respiratory Distress Syndrome, including COVID-19 NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;...
Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy
Novartis enters into exclusive worldwide license with Mesoblast to develop, commercialize and manufacture remestemcel-L for treatment of acute respiratory distress...
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
1-for-4 Reverse Stock Split to be Effective November 20, 2020 HOPKINTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Spring Bank...
Mesoblast Corporate Update and Financial Results Webcast
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
SmileDirectClub Launches Foundation to Empower Those Navigating Transitions
Company Builds Corporate Responsibility Effort, Partners with Organizations Focused on Helping People Find and Boost Confidence NASHVILLE, Tenn., Nov. 19,...
Phathom Pharmaceuticals to Host Virtual Investor Day
Event to be webcast on Monday, December 14, 2020 at 1:00 PM (ET) FLORHAM PARK, N.J., Nov. 19, 2020 (GLOBE...
Matinas BioPharma to Participate in Annual Piper Sandler Healthcare Conference
BEDMINSTER, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused...
Aziyo Biologics Reports Third Quarter 2020 Financial Results
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused...
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress
– Human clinical testing now underway with Codiak’s first two candidates, exoIL-12™ and exoSTING™ – – Initial safety results and preliminary...
Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in Blood
The phase 1b study showed a complete response (CR) rate of 46% (objective response rate of 88%) at the...
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
Dr. Isaac Rodriguez-Chavez brings vast expertise in regulatory compliance and clinical research methodology to PRA’s industry-leading DCT practice Dr. Isaac...
Golden Leaf Holdings Announces First Cashflow-Positive Quarter and Record Quarterly Revenues
Operational Excellence a key driver of financial results TORONTO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE:GLH)...
Eargo Reports Third Quarter 2020 Financial Results
Third Quarter and Recent Highlights: Net revenues of $18.2 million, up 135.3% year-over-year Gross systems shipped of 10,077, up 91.7%...